These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Implementation of the neonatal cystic fibrosis screening program in Switzerland: beginning January 2011]. Mornand A; Barben J; Hafen G Rev Med Suisse; 2011 Feb; 7(283):456, 458-60. PubMed ID: 21452515 [TBL] [Abstract][Full Text] [Related]
43. Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening. Korzeniewski SJ; Young WI; Hawkins HC; Cavanagh K; Nasr SZ; Langbo C; Teneyck KR; Grosse SD; Kleyn M; Grigorescu V Pediatr Pulmonol; 2011 Feb; 46(2):125-30. PubMed ID: 20848586 [TBL] [Abstract][Full Text] [Related]
44. Outcomes of infants with indeterminate diagnosis detected by cystic fibrosis newborn screening. Ren CL; Fink AK; Petren K; Borowitz DS; McColley SA; Sanders DB; Rosenfeld M; Marshall BC Pediatrics; 2015 Jun; 135(6):e1386-92. PubMed ID: 25963008 [TBL] [Abstract][Full Text] [Related]
46. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. Mayell SJ; Munck A; Craig JV; Sermet I; Brownlee KG; Schwarz MJ; Castellani C; Southern KW; J Cyst Fibros; 2009 Jan; 8(1):71-8. PubMed ID: 18957277 [TBL] [Abstract][Full Text] [Related]
47. Cystic fibrosis newborn screening: a pilot study to maximize carrier screening. Lagoe E; Labella S; Arnold G; Rowley PT Genet Test; 2005; 9(3):255-60. PubMed ID: 16225405 [TBL] [Abstract][Full Text] [Related]
48. Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening. Rock MJ; Levy H; Zaleski C; Farrell PM Pediatr Pulmonol; 2011 Dec; 46(12):1166-74. PubMed ID: 22081556 [TBL] [Abstract][Full Text] [Related]
49. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis. Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936 [TBL] [Abstract][Full Text] [Related]
50. Predictors of insufficient sweat production during confirmatory testing for cystic fibrosis. Kleyn M; Korzeniewski S; Grigorescu V; Young W; Homnick D; Goldstein-Filbrun A; Schuen J; Nasr S Pediatr Pulmonol; 2011 Jan; 46(1):23-30. PubMed ID: 20812243 [TBL] [Abstract][Full Text] [Related]
51. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing. Dhondt JL J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772 [TBL] [Abstract][Full Text] [Related]
52. New York State cystic fibrosis consortium: the first 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population. Giusti R; Badgwell A; Iglesias AD; Pediatrics; 2007 Feb; 119(2):e460-7. PubMed ID: 17272608 [TBL] [Abstract][Full Text] [Related]
53. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Kloosterboer M; Hoffman G; Rock M; Gershan W; Laxova A; Li Z; Farrell PM Pediatrics; 2009 Feb; 123(2):e338-46. PubMed ID: 19171585 [TBL] [Abstract][Full Text] [Related]
54. Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control. Sands D; Ołtarzewski M; Nowakowska A; Zybert K Folia Histochem Cytobiol; 2010 Sep; 48(3):358-65. PubMed ID: 21071339 [TBL] [Abstract][Full Text] [Related]
55. A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. Terlizzi V; Claut L; Tosco A; Colombo C; Raia V; Fabrizzi B; Lucarelli M; Angeloni A; Cimino G; Castaldo A; Marsiglio L; Timpano S; Cirilli N; Moroni L; Festini F; Piccinini P; Zavataro L; Bonomi P; Taccetti G; Southern KW; Padoan R J Cyst Fibros; 2021 Sep; 20(5):828-834. PubMed ID: 33883100 [TBL] [Abstract][Full Text] [Related]
56. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. Grosse SD; Boyle CA; Botkin JR; Comeau AM; Kharrazi M; Rosenfeld M; Wilfond BS; MMWR Recomm Rep; 2004 Oct; 53(RR-13):1-36. PubMed ID: 15483524 [TBL] [Abstract][Full Text] [Related]